Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

898 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group.
Lochs H, Adler G, Beglinger C, Duchmann R, Emmrich J, Ewe K, Gangl A, Gasché C, Hahn E, Hoffmann P, Kaskas B, Malchow H, Pohl C, Raedler A, Renner E, Schölmerich J, Schreiber S, Stange E, Tilg H, Vogelsang H, Weigert N, Zeitz M. Lochs H, et al. Among authors: scholmerich j. Z Gastroenterol. 1999 Jun;37(6):509-12. Z Gastroenterol. 1999. PMID: 10427657 Clinical Trial.
[Diagnostics and treatment of Crohn's disease -- results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases].
Stange EF, Schreiber S, Fölsch UR, von Herbay A, Schölmerich J, Hoffmann J, Zeitz M, Fleig WE, Buhr HJ, Kroesen AJ, Moser G, Matthes H, Adler G, Reinshagen M, Stein J; German Society for Digestive and Metabolic Diseases. Stange EF, et al. Among authors: scholmerich j. Z Gastroenterol. 2003 Jan;41(1):19-20. doi: 10.1055/s-2003-36661. Z Gastroenterol. 2003. PMID: 12541167 Review. German. No abstract available.
[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease].
Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, Dignass A, Fischer I, Fleig W, Fölsch UR, Herrlinger K, Höhne W, Jantschek G, Kaltz B, Keller KM, Knebel U, Kroesen AJ, Kruis W, Matthes H, Moser G, Mundt S, Pox C, Reinshagen M, Reissmann A, Riemann J, Rogler G, Schmiegel W, Schölmerich J, Schreiber S, Schwandner O, Selbmann HK, Stange EF, Utzig M, Wittekind C. Hoffmann JC, et al. Among authors: scholmerich j. Z Gastroenterol. 2004 Sep;42(9):979-83. doi: 10.1055/s-2004-813510. Z Gastroenterol. 2004. PMID: 15455267 Review. German. No abstract available.
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization.
Herfarth H, Gross V, Andus T, Caesar I, Vogelsang H, Adler G, Malchow H, Petri A, Gierend M, Schölmerich J; German/Austrian Budesonide Study Group. Herfarth H, et al. Among authors: scholmerich j. Int J Colorectal Dis. 2004 Mar;19(2):147-52. doi: 10.1007/s00384-003-0529-5. Epub 2003 Sep 9. Int J Colorectal Dis. 2004. PMID: 13680283 Clinical Trial.
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases].
Stange EF, Riemann J, von Herbay A, Lochs H, Fleig WE, Schölmerich J, Kruis W, Porschen R, Bruch HP, Zeitz M, Schreiber S, Moser G, Matthes H, Selbmann HK, Goebell H, Caspary WF. Stange EF, et al. Among authors: scholmerich j. Z Gastroenterol. 2001 Jan;39(1):19-20. doi: 10.1055/s-2001-10692. Z Gastroenterol. 2001. PMID: 11215358 Review. German. No abstract available.
898 results